Tumor-infiltrating clonal hematopoiesis is associated with worse outcomes in patients with cancer, new research suggests.

The published long-term data suggests that the treatment could maintain its dominant position in the CF market.

Researchers have traced where and when the HIV protective mutation arose but also how it gave northern European ancestors a competitive advantage against ancient diseasesA genetic mutation in a ...